BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 28355589)

  • 21. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
    Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
    Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines.
    Lidor YJ; Lee WE; Nilson JH; Maxwell IH; Su LJ; Brand E; Glode LM
    Am J Obstet Gynecol; 1997 Sep; 177(3):579-85. PubMed ID: 9322627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer.
    Zhang Z; Zhou B; Zhang J; Chen Y; Lai T; Yan L; Liang A; Li Y; Wang Y; Chen Y; Zhang L; Xi MR
    Cancer Genet Cytogenet; 2010 Jan; 196(2):146-52. PubMed ID: 20082850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population.
    Pawlik P; Mostowska A; Lianeri M; Sajdak S; Kędzia H; Jagodzinski PP
    Mol Biol Rep; 2012 May; 39(5):5553-60. PubMed ID: 22183302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.
    Chen Y; Kibriya MG; Jasmine F; Santella RM; Senie RT; Ahsan H
    Cancer Res; 2008 Dec; 68(23):9729-34. PubMed ID: 19047151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between interleukin-6 (G174C and C572G) promoter gene polymorphisms and risk of ischemic stroke in North Indian population: a case-control study.
    Kumar P; Kumar A; Sagar R; Misra S; Faruq M; Suroliya V; Vivekanandhan S; Kumar Srivastava A; Prasad K
    Neurol Res; 2016 Jan; 38(1):69-74. PubMed ID: 26883819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.
    Costa S; Pinto D; Pereira D; Vasconcelos A; Afonso-Lopes C; Osório T; Lopes C; Medeiros R
    Cancer Lett; 2007 Feb; 246(1-2):324-30. PubMed ID: 16677755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of human chorionic gonadotropin beta subunit transcripts in ovarian cancer tissue.
    Nowak-Markwitz E; Jankowska A; Szczerba A; Andrusiewicz M; Warchoł JB
    Folia Histochem Cytobiol; 2004; 42(2):123-6. PubMed ID: 15253136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants.
    Suttner K; Rosenstiel P; Depner M; Schedel M; Pinto LA; Ruether A; Adamski J; Klopp N; Illig T; Vogelberg C; Schreiber S; von Mutius E; Kabesch M
    J Allergy Clin Immunol; 2009 May; 123(5):1062-8, 1068.e1-8. PubMed ID: 19362357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single nucleotide polymorphisms (SNPs) of hOGG1 and XRCC1 DNA repair genes and the risk of ovarian cancer in Polish women.
    Michalska MM; Samulak D; Romanowicz H; Bieńkiewicz J; Sobkowski M; Ciesielski K; Smolarz B
    Tumour Biol; 2015 Dec; 36(12):9457-63. PubMed ID: 26124010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CCR2 (+190 G/A) Gene Variants and Ovarian Cancer Severity.
    Yildirim G; Attar R; Gulec-Yilmaz S; Duman S; Isbir T
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):512-515. PubMed ID: 28650671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis.
    Qiu XS; Tang NL; Yeung HY; Lee KM; Hung VW; Ng BK; Ma SL; Kwok RH; Qin L; Qiu Y; Cheng JC
    Spine (Phila Pa 1976); 2007 Jul; 32(16):1748-53. PubMed ID: 17632395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotyping of IRGM tetranucleotide promoter oligorepeats by fluorescence resonance energy transfer.
    Intemann CD; Thye T; Sievertsen J; Owusu-Dabo E; Horstmann RD; Meyer CG
    Biotechniques; 2009 Jan; 46(1):58-60. PubMed ID: 19301623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
    Yang CQ; Chan KY; Ngan HY; Khoo US; Chiu PM; Chan QK; Xue WC; Cheung AN
    Carcinogenesis; 2006 Jul; 27(7):1502-6. PubMed ID: 16574671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.
    Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
    BMC Cancer; 2017 Feb; 17(1):97. PubMed ID: 28158999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.